Charles River acquires antibody discovery company Distributed Bio for $83M

Charles River Laboratories International Inc. bought antibody discovery company Distributed Bio Inc. for $83 million in cash.

The transaction, which was financed by an existing revolving credit facility and cash, closed Dec. 31, 2020.

Under the deal, Distributed Bio may be eligible for contingent additional payments of up to $21 million based on future performance.

Charles River noted that Distributed Bio's estimated annual revenue for 2020 was about $15 million.